Cargando…
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk pati...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545996/ https://www.ncbi.nlm.nih.gov/pubmed/31179020 http://dx.doi.org/10.15420/cfr.2018.41.2 |
_version_ | 1783423481526878208 |
---|---|
author | Spitzer, Ernest Hahn, Rebecca T Pibarot, Philippe de Vries, Ton Bax, Jeroen J Leon, Martin B Van Mieghem, Nicolas M |
author_facet | Spitzer, Ernest Hahn, Rebecca T Pibarot, Philippe de Vries, Ton Bax, Jeroen J Leon, Martin B Van Mieghem, Nicolas M |
author_sort | Spitzer, Ernest |
collection | PubMed |
description | Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk patients to patients with intermediate risk. Assessment of heart failure-related outcomes include the use of functional assessments, disease-specific quality of life surveys and standardised ascertainment of events, such as hospitalisations. Multiple statistical approaches are currently being tested to account for recurrent events such as hospitalisations for heart failure or to combine binary and continuous outcomes, both intended to assess the holistic burden of the disease, as opposed to the traditional analysis of time to first event. |
format | Online Article Text |
id | pubmed-6545996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Radcliffe Cardiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-65459962019-06-07 Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials Spitzer, Ernest Hahn, Rebecca T Pibarot, Philippe de Vries, Ton Bax, Jeroen J Leon, Martin B Van Mieghem, Nicolas M Card Fail Rev Co-Morbidities Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk patients to patients with intermediate risk. Assessment of heart failure-related outcomes include the use of functional assessments, disease-specific quality of life surveys and standardised ascertainment of events, such as hospitalisations. Multiple statistical approaches are currently being tested to account for recurrent events such as hospitalisations for heart failure or to combine binary and continuous outcomes, both intended to assess the holistic burden of the disease, as opposed to the traditional analysis of time to first event. Radcliffe Cardiology 2019-05-24 /pmc/articles/PMC6545996/ /pubmed/31179020 http://dx.doi.org/10.15420/cfr.2018.41.2 Text en Copyright © 2019, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
spellingShingle | Co-Morbidities Spitzer, Ernest Hahn, Rebecca T Pibarot, Philippe de Vries, Ton Bax, Jeroen J Leon, Martin B Van Mieghem, Nicolas M Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title | Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_full | Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_fullStr | Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_full_unstemmed | Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_short | Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_sort | aortic stenosis and heart failure: disease ascertainment and statistical considerations for clinical trials |
topic | Co-Morbidities |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545996/ https://www.ncbi.nlm.nih.gov/pubmed/31179020 http://dx.doi.org/10.15420/cfr.2018.41.2 |
work_keys_str_mv | AT spitzerernest aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT hahnrebeccat aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT pibarotphilippe aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT devrieston aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT baxjeroenj aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT leonmartinb aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT vanmieghemnicolasm aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials |